KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Short-term Investments (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Short-term Investments for 14 consecutive years, with $180.2 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 53.1% to $180.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $180.2 million through Dec 2025, down 53.1% year-over-year, with the annual reading at $180.2 million for FY2025, 53.1% down from the prior year.
  • Short-term Investments for Q4 2025 was $180.2 million at Supernus Pharmaceuticals, up from $129.8 million in the prior quarter.
  • The five-year high for Short-term Investments was $384.3 million in Q4 2024, with the low at $105.2 million in Q3 2023.
  • Average Short-term Investments over 5 years is $231.1 million, with a median of $191.9 million recorded in 2022.
  • The sharpest move saw Short-term Investments surged 253.16% in 2024, then tumbled 65.07% in 2025.
  • Over 5 years, Short-term Investments stood at $136.2 million in 2021, then surged by 170.26% to $368.2 million in 2022, then tumbled by 51.16% to $179.8 million in 2023, then surged by 113.7% to $384.3 million in 2024, then plummeted by 53.1% to $180.2 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $180.2 million, $129.8 million, and $377.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.